On this page
What this guide covers
Mounjaro (tirzepatide) copies two gut hormones at once, GIP and GLP-1, which is what sets it apart from the single-hormone drugs. Here is what those hormones do, why the dual action matters, and how the effect builds week by week. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).
Key points
- It mimics two hormones, not one. Mounjaro's active ingredient is tirzepatide, and the thing that makes it different from Ozempic or Wegovy is that it acts on two receptors instead of one. It copies GLP-1, the hormone most people have heard of, and it also copies GIP, a second gut hormone that the older drugs leave alone. Both are incretins, hormones your gut releases after you eat, and both nudge the body toward using food more efficiently. Because tirzepatide switches on both pathways, it is often called a dual agonist, and that dual action is the headline reason it behaves a little differently from the single-hormone drugs.
- What GLP-1 does. The GLP-1 side of tirzepatide does the work you would expect from any GLP-1 drug. It tells the pancreas to release insulin when blood sugar is high, and it quiets the hormone glucagon that pushes sugar up, so blood glucose steadies. It also slows how fast the stomach empties, so food sits longer and you feel full sooner. And it acts on appetite centers in the brain, turning down the background hunger and the constant food thoughts many people describe. Together those effects mean smaller portions feel like enough.
- What the added GIP does. GIP is the piece the older drugs do not touch, and researchers are still mapping exactly how much it adds. The current understanding is that GIP works alongside GLP-1 on insulin release and appears to influence how the body handles fat and further dampens appetite through separate brain signals. In the head-to-head diabetes trial that compared tirzepatide with semaglutide, tirzepatide produced larger drops in blood sugar and body weight, and the extra GIP action is the leading explanation for that gap, though the science is not fully settled.
- Why the dose climbs slowly. You do not start Mounjaro at a working dose. It begins at 2.5 mg once a week, which is a starter dose meant to let your gut adjust, and it steps up no faster than every four weeks toward a maintenance dose. This slow climb is not the manufacturer being cautious for its own sake. The nausea, fullness, and gut upset that come with these drugs are worst when the dose jumps, so easing up gives the stomach time to settle. It also means the full effect is not a day-one event; it builds over the weeks as the dose rises.
- What it does not do. Mounjaro is not insulin and it is not a stimulant. It does not burn fat directly or speed up your metabolism in the way a fat-burner claims to. It works by changing hunger and how your body handles sugar, so the weight change follows from eating less and steadier blood sugar, not from the drug melting anything. It also stops working when you stop taking it. The appetite signals return, which is why prescribers treat it as a long-term medication rather than a short course.
Frequently asked questions
How is Mounjaro different from Ozempic?
Ozempic (semaglutide) copies one hormone, GLP-1. Mounjaro (tirzepatide) copies two, GLP-1 and GIP. That dual action is the main structural difference, and in a head-to-head diabetes trial tirzepatide led to larger blood-sugar and weight reductions than semaglutide. Both are once-weekly injections and both work mainly by reducing appetite and steadying blood sugar.
Is Mounjaro insulin?
No. Mounjaro does not contain insulin. It prompts your own pancreas to release insulin when your blood sugar is high, and it quiets the hormone that raises blood sugar, but it is not insulin itself. That distinction matters, because on its own it is far less likely to cause a low-blood-sugar crash than injected insulin.
How long does Mounjaro take to work?
Appetite and fullness usually shift within the first week or two, but Mounjaro is dosed to climb slowly, stepping up no sooner than every four weeks, so the fuller effect builds over the first couple of months as the dose rises. Blood-sugar improvements in people with diabetes often show up early and continue as the dose increases.
Does Mounjaro speed up your metabolism?
Not in the fat-burner sense. It works by reducing hunger and steadying blood sugar so you eat less, rather than by revving your metabolism. The weight change follows from the appetite change. That is also why the effect fades when the drug is stopped and the hunger signals return.
Is the weight change permanent?
The medication's effect is not. Mounjaro changes hunger and blood sugar only while it is in your system, so appetite tends to return after stopping and some regain is common. Prescribers generally treat it as an ongoing medication, and any plan to stop is a conversation to have with the person who prescribed it.
Sources
Related reading
Is Mounjaro Insulin? Clearing Up a Common Mix-Up
Mounjaro is an injection used in diabetes, so people reasonably ask if it is insulin. It is not. Here is what Mounjaro actually is, how it differs from insulin, and why the distinction matters for safety.
Zepbound for Sleep Apnea: What the Approval Means
Zepbound is the first drug FDA-approved for obstructive sleep apnea in adults with obesity. Here is how a weight medication came to treat a breathing disorder, what the trial showed, and what it does not replace.
The Wegovy Pill: Oral Semaglutide, Explained
An oral form of semaglutide for weight management brings the question everyone asks: does the pill work as well as the injection? Here is how the tablet differs, what the trials suggest, and the fine print on taking it.